ADPT - Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call Transcript

2025-08-06 02:13:34 ET

Adaptive Biotechnologies Corporation (ADPT)

Q2 2025 Earnings Conference Call

August 05, 2025, 04:30 PM ET

Company Participants

Chad M. Robins - Co-Founder, CEO & Chairman

Karina Calzadilla - Vice President of Investor Relations

Kyle Piskel - VP, CFO & Principal Accounting Officer

Susan Bobulsky - Chief Commercial Officer of MRD

Conference Call Participants

Andrew Frederick Brackmann - William Blair & Company L.L.C., Research Division

Daniel Gregory Brennan - TD Cowen, Research Division

David Michael Westenberg - Piper Sandler & Co., Research Division

Mark Anthony Massaro - BTIG, LLC, Research Division

Sebastian L. Sandler - JPMorgan Chase & Co, Research Division

Yuko Oku - Morgan Stanley, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded....

For further details see: